• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Hypoxia tolerance of cancer cells through suppression of mTOR signaling

Research Project

Project/Area Number 17590284
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pathological medical chemistry
Research InstitutionOsaka Medical Center for Cancer and Cardiovascular Diseases Osaka Prefectural Hospital Organization

Principal Investigator

INOUE Masahiro  Osaka Medical Center for Cancer and Cardiovascular Diseases Osaka Prefectural Hospital Organization, Biochemistry, director, 研究所, 総括研究員 (10342990)

Co-Investigator(Kenkyū-buntansha) MUKAI Mutsuko  Osaka Medical Center for Cancer and Cardiovascular Diseases Osaka Prefectural Hospital Organization, Principal investigator, 研究所, 主任研究員 (20342991)
Project Period (FY) 2005 – 2006
Project Status Completed (Fiscal Year 2006)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2006: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 2005: ¥2,200,000 (Direct Cost: ¥2,200,000)
Keywordshypoxia / mTOR / PI3K / apoptosis / P13K
Research Abstract

mTOR (mammalian target of rapamycin) is activated and contributes to proliferation and survival of cancer cells under oxygenated and nutritionally rich conditions. On the other hand, under hypoxic and nutritionally poor conditions, mTOR signal is suppressed, although the physiological role of the suppression had not been clarified. This study aimed at elucidating the correlation between the suppression of mTOR signaling and cancer cell survival under hypoxic conditions.
First, we examined the molecular mechanism in vitro. In a colon cancer cell line, COLO 320, which is hypoxia sensitive, over-expression of Rheb as well as eIF4E activated mTOR signaling even under hypoxic conditions. Rheb and eIF4E introduced cells were more sensitive to hypoxia. The death was circumvented by inhibition of PI3K or mTOR. On the other hand, in a pancreas cancer cell line, AsPC-1, which is hypoxia tolerant, neither rheb nor eIF4E could activate mTOR signaling under hypoxic conditions. We also tried TAT-ODD system equipped with active form of Rheb. AsPC-1 cells treated with TAT-ODD-rheb could not stimulate mTOR signaling under hypoxic conditions. Together, in AsPC-1 cells, other factors in addition to rheb are necessary to activate mTOR signaling under hypoxic conditions.
We found that IGF stimulation generated massive apoptosis in COLO 320 cells in hypoxia as well as AsPC-1 cells in anoxia. IGF induced robust endoplasmic reticulum stress, ER stress, under hypoxic conditions, and the ER stress was necessary for apoptosis. Especially, we revealed that CHOP induction was critical for the cell death (Cancer Research, in revision). We also found that phosphorylation of S6, a downstream event of mTOR activation, was suppressed under hypoxic area compared with well oxygenized area. Since, we could not activate mTOR signaling under hypoxic area in vivo, the role of mTOR suppression in vivo remains to be elucidated.

Report

(3 results)
  • 2006 Annual Research Report   Final Research Report Summary
  • 2005 Annual Research Report
  • Research Products

    (10 results)

All 2006 2005

All Journal Article (10 results)

  • [Journal Article] RhoC is essential for TGF-beta1-induced invasive capacity of rat ascites hepatoma cells2006

    • Author(s)
      Mukai M., Endo H., Iwasaki T., et al.
    • Journal Title

      Biochem Biophys Res Commun 346・1

      Pages: 74-82

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] RhoC is essential for TGF-beta1-induced invasive capacity of rat ascites hepatoma cells2006

    • Author(s)
      Mukai M., Endo H., Iwasaki T., et al.
    • Journal Title

      Biochem Biophys Res Commun 346.1

      Pages: 74-82

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Inactivation of Rho GTPases by p190 RhoGAP reduces human pancreatic cancer cell invasion and metastasis2006

    • Author(s)
      Kusama T, Mukai M, Endo H., et al.
    • Journal Title

      Cancer Science 97.8

      Pages: 843-853

    • NAID

      10018767306

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho2006

    • Author(s)
      Kusama T, Mukai M, Tatsuta M., et al.
    • Journal Title

      International Journal of Oncology 29.1

      Pages: 217-23

    • Related Report
      2006 Annual Research Report
  • [Journal Article] RhoC is essential for TGF-beta1-induced invasive capacity of rat ascites hepatoma cells2006

    • Author(s)
      Mukai M, Endo H, Iwasaki T., et al.
    • Journal Title

      Biochem Biophys Res Commun 346.1

      Pages: 74-82

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Cross talk between apoptosis and invasion signaling in cancer cells through caspase-3 activation.2005

    • Author(s)
      Mukai M, Kusama T, Hamanaka Y, et al.
    • Journal Title

      Cancer Res 65

      Pages: 9121-9125

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Transforming growth factor-beta1 induces LMO7 while enhancing the invasiveness of rat ascites hepatoma cells.2005

    • Author(s)
      Nakamura H, Mukai M, Komatsu K, et al.
    • Journal Title

      Cancer Lett 220

      Pages: 95-99

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Cross talk between apoptosis and invasion signaling in cancer cells through casupase-3 activation.2005

    • Author(s)
      Mukai M, Kusama T, Hamanaka Y, et al.
    • Journal Title

      Cancer Res 65

      Pages: 9121-9125

    • Related Report
      2005 Annual Research Report
  • [Journal Article] Suppression of PI3K/mTOR pathway rescues LLC cells from cell death induced by hypoxia.2005

    • Author(s)
      Hamanaka Y, Mukai M, Shimamura M, et al.
    • Journal Title

      Biochem Biophys Res Commun 330

      Pages: 318-326

    • Related Report
      2005 Annual Research Report
  • [Journal Article] CD4+ T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer.2005

    • Author(s)
      Daniel D, Chiu C, Giraudo E, et al.
    • Journal Title

      Cancer Res 65

      Pages: 2018-2025

    • Related Report
      2005 Annual Research Report

URL: 

Published: 2005-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi